Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;41(10):1193-1201.
doi: 10.1002/pd.5952. Epub 2021 May 7.

Cell-free fetal DNA coming in all sizes and shapes

Affiliations
Review

Cell-free fetal DNA coming in all sizes and shapes

Rossa W K Chiu et al. Prenat Diagn. 2021 Sep.

Abstract

Cell-free fetal DNA analysis has an established role in prenatal assessments. It serves as a source of fetal genetic material that is accessible non-invasively from maternal blood. Through the years, evidence has accumulated to show that cell-free fetal DNA molecules are derived from placental tissues, are mainly of short DNA fragments and have rapid post-delivery clearance profiles. But questions regarding how they come to being short molecules from placental cells and in which physical forms do they exist remained largely unanswered until recently. We now know that the distributions of ending sites of cell-free DNA molecules are non-random across the genome and bear correlations with the chromatin structures of cells from which they have originated. Such an insight offers ways to deduce the tissue-of-origin of these molecules. Besides, the physical nature and sequence characteristics of the ends of each cell-free DNA molecule provide tell-tale signs of how the DNA fragmentation processes are orchestrated by nuclease enzymes. These realizations offered opportunities to develop methods for enriching cell-free fetal DNA to facilitate non-invasive prenatal diagnostics. Here we aimed to collate what is known about the biological and physical characteristics of cell-free fetal DNA into one article and explain the implications of these observations.

PubMed Disclaimer

Conflict of interest statement

R.W.K.C. and Y.M.D.L. are supported by the Hong Kong Research Grants Council Theme‐Based Research Scheme (T12‐401/16‐W) and an InnoHK grant from the Innovation and Technology Commission.

R.W.K.C. and Y.M.D.L. have filed patents on aspects of cell‐free DNA analysis; hold equities in DRA, Take2 and Grail; are Founders and Directors of DRA and Take2; are consultants to Grail; and receive patent royalties from Illumina, Sequenom, Xcelom, Grail, DRA and Take2. Y.M.D.L is a Scientific Co‐Founder and serves on the Advisory Board of Grail. R.W.K.C. is a consultant to Illumina.

Figures

FIGURE 1
FIGURE 1
Pictorial glossary. Illustrations to depict some of the terms referred to in the text. Cell‐free DNA molecules mostly circulate as short double‐stranded fragments with end termini that are blunt or jagged in nature. A blunt end is when both strands of a double‐stranded DNA molecule end at the same genomic location. A jagged end is present when each strand of a double‐stranded DNA molecule ended at different genomic locations. If the 5′ end of one strand protrudes more, the end is said to show a 5′ overhang. If a 3′ end of one strand protrudes more, the end is said to show a 3′ overhang. A small proportion of cell‐free DNA molecules are single‐stranded. The ends of cell‐free DNA molecules, whether double‐ or single‐stranded, show characteristic sequences, termed motifs. For example, a 4‐nucleotide motif is termed a 4‐mer end motif. Double‐stranded cell‐free DNA molecules usually circulate in a form where they are wound around histone proteins in the form of a nucleosome subunit. When the double‐helical structure of DNA is wound around histones, it exposes the minor grooves of the 3‐dimensional structure at the external surface of the nucleosome which are susceptible to nuclease digestion. When many cell‐free DNA molecules are aligned to the genome coordinates, it is noted that more molecules cover certain regions than others. This periodic coverage pattern is reflective of where protein‐binding, e.g. histones and transcription factors, is present in the cellular DNA and hence are sites protected from nuclease enzymes during the production of cell‐free DNA. One could also determine the genomic locations of cell‐free DNA ending sites which occur more frequently at certain locations than others. Sites with high ending frequencies are termed preferred ends

Comment in

References

    1. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485‐487. - PubMed
    1. Van Der Meij KRM, Sistermans EA, Macville MVE, et al. TRIDENT‐2: National implementation of genome‐wide non‐invasive prenatal testing as a first‐tier screening test in The Netherlands. Am J Hum Genet. 2019;105:1091‐1101. - PMC - PubMed
    1. Lund ICB, Petersen OB, Becher NH, et al. National data on the early clinical use of non‐invasive prenatal testing in public and private healthcare in Denmark 2013‐2017. Acta Obstet Gynecol Scand. 2021;100:884‐892. 10.1111/aogs.14052.Nov 24 - DOI - PubMed
    1. Lun FMF, Tsui NBY, Chan KCA, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U. S. A. 2008;105:19920‐19925. - PMC - PubMed
    1. Chandler NJ, Ahlfors H, Drury S, et al. Noninvasive prenatal diagnosis for cystic fibrosis: implementation, uptake, outcome, and implications. Clin Chem. 2020;66:207‐216. - PubMed

Substances